Gentamicin susceptibility of Neisseria gonorrhoeae isolates from 7 provinces in China

References

• National Health Commission of the PRC [homepage on the Internet]. Overview of the national epidemic of infectious diseases in 2018; 2018 Available from: http://www.nhc.gov.cn/jkj/s3578/201904/050427ff32704a5db64f4ae1f6d57c6c.shtml. Accessed 501, 2019.
   Google Scholar
• Cohen MS. Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis. 2012;206(1):1–2. doi:10.1093/infdis/jis30322517911
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman SM, Douglas JM. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148(8):606–613. doi:10.7326/0003-4819-148-8-200804150-0000518413622
   PubMed Web of Science ®Google Scholar
• Wang F, Liu J, Liu H, et al Evaluation of the accuracy of molecular assays targeting the mutation A2059G for detecting high-level azithromycin resistance in Neisseria gonorrhoeae: a systematic review and meta-analysis. Infect Drug Resist. 2019;12:95–104. doi:10.2147/IDR.S18375430643437
   PubMed Web of Science ®Google Scholar
• Han Y, Yin YP, Zhou Y, et al Nonadherence to national guidelines for antibiotic treatment of uncomplicated gonorrhea in China: results from a nationwide survey. Sex Transm Dis. 2018;45(9):600–606. doi:10.1097/OLQ.000000000000081930102261
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587–613. doi:10.1128/CMR.00010-1424982323
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bolan GA; for Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR–03):1–137.
   PubMed Web of Science ®Google Scholar
• Yin YP, Han Y, Dai XQ, et al Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15(2):e1002499. doi:10.1371/journal.pmed.100259329408881
   PubMed Web of Science ®Google Scholar
• Boslego JW, Tramont EC, Takafuji ET, et al Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987;317(5):272–278. doi:10.1056/NEJM1987073031705042955222
   PubMed Web of Science ®Google Scholar
• Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85–92. doi:10.1177/095646241247283724400344
   PubMed Web of Science ®Google Scholar
• World Health Organization [homepage on the Internet]. WHO guidelines for the treatment of Neisseria gonorrhoeae; 2016 Available from: http://apps.who.int/iris/bitstream/10665/246114/1/9789241549691-eng.pdf?ua=1. Accessed 501, 2019.
   Google Scholar
• Ross JD, Lewis DA. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex Transm Infect. 2012;88(1):6–8. doi:10.1136/sextrans-2011-05036222250178
   PubMed Web of Science ®Google Scholar
• Ye S, Su X, Wang Q, Yin Y, Dai X, Sun H. Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993–1998. Sex Transm Dis. 2002;29(4):242–245.11912467
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing [homepage on the Internet]. Breakpoint tables for interpretation of MICs and zone diameters, version 8.1; 2019 Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_8.1_Breakpoint_Tables.pdf. Accessed 501, 2019.
   Google Scholar
• Daly CC, Hoffman I, Hobbs M, et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol. 1997;35(11):2985–2988.9350775
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Sanchez-Buso L, et al The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother. 2016;71(11):3096–3108. doi:10.1093/jac/dkw28827432602
   PubMed Web of Science ®Google Scholar
• Brown LB, Krysiak R, Kamanga G, et al Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis. 2010;37(3):169–172. doi:10.1097/OLQ.0b013e3181bf575c19901860
   PubMed Web of Science ®Google Scholar
• Kirkcaldy RD, Weinstock HS, Moore PC, et al The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis. 2014;59(8):1083–1091. doi:10.1093/cid/ciu52125031289
   PubMed Web of Science ®Google Scholar
• Ross JD, Brittain C, Cole M, et al. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Lancet. 2019;393(10190):2511–2520. doi:10.1016/S0140-6736(18)32817-431056291
   PubMed Web of Science ®Google Scholar
• Mann LM, Kirkcaldy RD, Papp JR, Torrone EA. Susceptibility of Neisseria gonorrhoeae to gentamicin-gonococcal isolate surveillance project, 2015–2016. Sex Transm Dis. 2018;45(2):96–98. doi:10.1097/OLQ.000000000000069329324629
   PubMed Web of Science ®Google Scholar
• Chisholm SA, Quaye N, Cole MJ, et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother. 2011;66(3):592–595. doi:10.1093/jac/dkq47621172790
   PubMed Web of Science ®Google Scholar
• Bala M, Singh V, Bhargava A, Kakran M, Joshi NC, Bhatnagar R. Gentamicin susceptibility among a sample of multidrug-resistant Neisseria gonorrhoeae isolates in India. Antimicrob Agents Chemother. 2016;60(12):7518–7521. doi:10.1128/AAC.01907-1627736753
   PubMed Web of Science ®Google Scholar
• Chen XS, Yin YP, Li XY. A ROADMAP plan to address research needs for gonococcal antimicrobial resistance in China. Clin Infect Dis. 2018;68(3):505–510. doi:10.1093/cid/ciy566
   Web of Science ®Google Scholar